UNSPSC 85819323: Transfusion of nonautologous fibrinogen into peripheral vein, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of nonautologous fibrinogen into peripheral vein, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30233T1

UNSPSC 85819323 Transfusion of nonautologous fibrinogen into peripheral vein, percutaneous approach is a Commodity code that shows little relevant recent state and local procurement activity. The six opportunities tagged to this code in the past three months span independent medical evaluation services for public safety retirement disability determinations, surgical and medical procedure carve-out benefits for city employee health plans, occupational medical surveillance for transportation workers, emergency and specialty medical services for youth in custody, pharmacy benefit management administration, and temporary health professional staffing — none of which involve transfusion of nonautologous fibrinogen or any blood product procurement. The mismatch between the code's nominal clinical scope and the actual work being solicited indicates that state and local purchasing offices are either using the code incorrectly or that this code does not reflect genuine buying activity in the state and local market.

The issuing bodies in the tagged opportunities span city retirement offices (Phoenix), city HR departments (Long Beach), state transportation agencies (Washington State Department of Transportation), county juvenile justice systems (Harris County), county human resources and health benefits offices (Collier County), and county health systems (Santa Clara). The recent opportunities reflect state and local government spending on benefits administration, occupational health services, and temporary health workforce management rather than clinical transfusion products or services. Without evidence of actual fibrinogen transfusion procurement in the recent opportunities block, this code presents no actionable opportunity signal for vendors supplying blood products or transfusion-related medical services to state and local buyers.